Two human induced pluripotent stem cell (iPSC) lines were generated from fibroblasts of two siblings with methylmalonic acidemia cblB type carrying mutations in the MMAB gene: c.287T➔C (p.Ile96Thr) and a splicing loss-of-function variant c.584G➔A affecting the last nucleotide of exon 7 in MMAB (p.Ser174Cysfs*23). Reprogramming factors OCT3/4, SOX2, KLF4 and c-MYC were delivered using a non-integrative method based on the Sendai virus. Once established, iPSCs have shown full pluripotency, differentiation capacity and genetic stability. 
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Resource utility
The iPSC lines were generated to investigate the pathophysiology of methylmalonic acidemia cblB type disease. In addition the effects of selected therapeutic compounds will be evaluated on disease-specific iPSC derived hepatocytes and neurons.
Resource details
Methylmalonic acidemia cblB type (MMA cblB type) is an inherited metabolic disease caused by mutations in the MMAB gene encoding ATP:cob(I)alamin adenosyltransferase that catalyses the synthesis of Stem Cell Research 29 (2018) 
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Stem Cell Research j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / s c r adenosylcobalamin (AdoCbl) from cobalamin using ATP (Froese and Gravel, 2010) . Fibroblasts from two siblings carrying the mutations c.287T➔C (p.Ile96Thr) and c.584G➔A (p.Ser174Cysfs*23) (Table 1) were reprogrammed using the CytoTune™ iPS Reprogramming kit delivering the four human reprogramming factors OCT3/4, SOX2, c-MYC and KLF4 (Takahashi et al., 2007) . The iPSC lines MMAB35-FiPS4F4 (UAMi002-A) and MMAB44-FiPS4F11 (UAMi003-A) displayed a typical round shape ESC-like morphology and growth behaviour (Fig. 1A , Table 2 ) and the colonies stained positive for alkaline phosphatase activity (Fig. 1B) . The clearance of the vectors and the exogenous reprogramming factor genes was observed by RT-PCR after 8 culture passages (Fig. 1C) . Expression of key pluripotency genes was observed both at protein level (transcription factors OCT4, NANOG and SOX2, and surface markers SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81) by immunocytochemistry (Fig. 1D , Table 2 ) and flow cytometry analysis (Fig. 1E , Table 2 ), as well as at RNA level (transcription factors OCT4, SOX2, REX1, NANOG, CRIPTO and KLF4) by qRT-PCR ( Supplementary  Fig. S1A ). The iPSC lines also displayed a normal karyotype (46, XX and 46, XY) after more than twenty culture passages (Fig. 1F ). The cells also had the capacity to form derivatives of all three germ layers (endoderm, mesoderm and ectoderm) upon embryoid body differentiation (Fig. 1G , Table 2 ). Mycoplasma testing by a colorimetry assay revealed a negative result ( Supplementary Fig. S1B ). We confirmed the presence of the two mutations in the iPSC lines by Sanger sequencing ( Supplementary Fig. S1C ); and we also confirmed by DNA fingerprinting analysis that the lines were derived from the patients´fibroblasts. In addition, methylation analysis of the promoters of the pluripotency associated genes, OCT4 and NANOG, revealed a heavy methylation in the original fibroblasts and an almost complete demethylation in the iPSC lines ( Supplementary Fig. S1D ).
Materials and methods

Non-integrative reprogramming of mutant MMAB fibroblasts into iPSC
The present study included available fibroblasts from two MMA cblB patients with defects in the MMAB gene (Table 1) . Experimental protocols were approved by the Institutional Ethical Committee of the Universidad Autónoma de Madrid according to Spanish and European Union legislation, and informed consents were obtained from the legal care-givers. Fibroblasts were reprogrammed using the CytoTune™ iPS Reprogramming kit (Life Technologies) following the manufacturer's instructions. iPSCs were maintained and expanded both on feeder layers and on feeder-free layers as previously described (AlonsoBarroso et al., 2017) .
Phosphatase alkaline analysis
Phosphatase alkaline analysis was performed as previously described (Alonso-Barroso et al., 2017).
Detection of Sendai virus genome and transgenes
After 8 passages, iPSC lines were tested for Sendai virus (SeV) residues as described (Alonso-Barroso et al., 2017) . PCR was performed using the primers indicated in Table 3 and following the instructions as recommended by the manufacturer. In Fig. 1 panel C: C+: transduced cell pool at passage zero; C−: non-template control.
Immunofluorescence analysis
Immunofluorescence analysis was performed as previously described (Alonso-Barroso et al., 2017). In Fig. 1 scale bars: 100 μm.
Flow cytometry analysis
We analysed the pluripotency-associated marker SSEA-4 by flow cytometry as described (Alonso-Barroso et al., 2017) .
Bisulfite sequencing
Bisulfite modification of genomic DNA was performed as previously described (Alonso-Barroso et al., 2017). Converted DNA was amplified by PCR using primers previously published (Freberg et al., 2007) and Immolase™ Red DNA Polymerase (Bioline). In Supplementary Fig. S1D each horizontal row of circles represents the methylation status of each CpG in one clone. Open circles indicate unmethylated CpG dinucleotides and filled circles, methylated.
In vitro differentiation
iPSC colonies were first cultured in suspension so that they form large aggregates called embryoid bodies, and in vitro differentiation was performed as described (Alonso-Barroso et al., 2017).
Quantitative PCR analysis
Quantitative PCR analysis was carried out as described (AlonsoBarroso et al., 2017) and the expression levels of several pluripotency associated genes (OCT4, SOX2, REX1, NANOG, CRIPTO and KLF4) were quantified. Primer sequences were described by Aasen et al., 2008 (Table 3) .
Mycoplasma detection
Cells were screened for mycoplasma contamination using a colorimetric assay, PlasmoTest™ Mycoplasma Detection Kit (InvivoGen), following the manufacturer's protocol. In Supplementary Fig. S1B : negative control (C−); positive control (C+).
Mutation analysis
Genomic DNA from the two patients-derived fibroblasts and iPSCs was isolated using MagNA Pure Compact DNA Isolation kit and MagNA Pure Compact instrument (Roche). Subsequently, amplification by PCR of the MMAB regions containing the mutations was carried out using the primers indicated in Table 3 , and amplified PCR fragments were sequenced in an ABI3730 sequencer (Applied Biosystems). 
Karyotype analysis
Karyotype analysis of the iPSC lines was carried out using cells with more than twenty culture passages which were processed using standard cytogenetic techniques as described (Alonso-Barroso et al., 2017) .
DNA fingerprinting analysis
DNA fingerprinting analysis was performed as previously described (Alonso-Barroso et al., 2017) .
Supplementary data to this article can be found online at https://doi. org/10.1016/j.scr.2018.03.021.
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